Plain-English translation of NCT07046468 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Researchers are testing a small, swallowable sensor device that measures oxidation-reduction potential โ essentially a marker of chemical stress โ directly in your colon. The study includes people with ulcerative colitis (a type of inflammatory bowel disease) and people with colorectal cancer. The goal is to see whether this sensor can detect disease activity before and after treatment, offering a less invasive alternative to traditional endoscopy.
Current methods to diagnose colon inflammation and cancer require uncomfortable endoscopy procedures. Researchers believe that measuring oxidative stress in the gut could become a simpler, less burdensome way to monitor disease and screen for cancer. This sensor technology might one day help doctors personalize treatment and improve cancer screening programs.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will swallow a small sensor pill about the size of a large vitamin (roughly 22 mm x 7.6 mm). The sensor will travel through your digestive system and measure chemical changes in your colon before and after your standard medical treatment. The device will exit your body naturally within 1โ2 weeks; researchers will track this using a temperature signal. If the sensor hasn't exited after 14 days, you may need a single X-ray to confirm it has passed. Your regular medical treatment will not be changed because of this study.
AI-generated summary from trial data ยท Jun 14, 2026 ยท Not medical advice
Netherlands